Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

INBS

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INBS
DatumZeitQuelleÜberschriftSymbolFirma
29/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
29/05/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyNASDAQ:INBSIntelligent Bio Solutions Inc
23/05/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
23/05/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsNASDAQ:INBSIntelligent Bio Solutions Inc
20/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
17/05/202414h30GlobeNewswire Inc.Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventNASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
18/04/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
11/04/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderNASDAQ:INBSIntelligent Bio Solutions Inc
26/03/202413h30GlobeNewswire Inc.Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCNASDAQ:INBSIntelligent Bio Solutions Inc
13/03/202400h30GlobeNewswire Inc.Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
11/03/202413h30GlobeNewswire Inc.Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
04/03/202423h26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INBSIntelligent Bio Solutions Inc
01/03/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
29/02/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
28/02/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayNASDAQ:INBSIntelligent Bio Solutions Inc
20/02/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
16/02/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementNASDAQ:INBSIntelligent Bio Solutions Inc
15/02/202400h04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
14/02/202402h08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
09/02/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
09/02/202414h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
09/02/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
07/02/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
05/02/202422h18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
05/02/202415h00GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsNASDAQ:INBSIntelligent Bio Solutions Inc
02/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
02/02/202414h30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
 Showing the most relevant articles for your search:NASDAQ:INBS